Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04793581 · ClinicalTrials.gov registry record · NA
Assessment of the Utility of the Pantheris Small Vessel (SV) System
A NA study of Peripheral Arterial Disease, sponsored by Avinger.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 2
- Study locations
NCT04793581: Recruiting NA study of Peripheral Arterial Disease, sponsored by Avinger.
NCT04793581 is a NA study of Peripheral Arterial Disease that is actively recruiting participants, run by Avinger. The registered enrollment target is 60 participants, below the 4,205-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04793581, a NA study of Peripheral Arterial Disease, is actively recruiting participants, sponsored by Avinger.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 2
- Study locations
Study Summary
A single-arm study to assess the utility of the Pantheris SV catheter in addressing peripheral artery disease in arteries located below the knee. Data will be collected on the percent stenosis pre- and post-atherectomy and then symptoms and adverse events noted at 30 days, 6 months, and 1 year after the procedure.
Conditions Studied
Interventions
- DEVICE Atherectomy
Study Locations (2)
Michigan
- Advanced Cardiac and Vascular Centers - Grand Rapids
- Eastlake Cardiovascular PC - Saint Clair Shores
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-01-29 |
| Est. Completion | 2025-08-01 |
| Phase | NA |
What NCT04793581 shows while recruiting
NCT04793581 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 4,205-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Peripheral Arterial Disease appearing as the primary indexed condition, and to 1 intervention - of which Atherectomy is the first listed.
NCT04793581 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT04793581 about?
NCT04793581 is a clinical study titled "Assessment of the Utility of the Pantheris Small Vessel (SV) System". A single-arm study to assess the utility of the Pantheris SV catheter in addressing peripheral artery disease in arteries located below the knee. Data will be collected on the percent stenosis pre- and post-atherectomy and then symptoms and adverse events noted at 30 days, 6 months, and 1 year after...
What is the current status of trial NCT04793581?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2021-01-29. Estimated completion is 2025-08-01.
What conditions does trial NCT04793581 study?
This clinical trial studies the following conditions: Peripheral Arterial Disease.
What interventions are being tested in trial NCT04793581?
The interventions under investigation include: Atherectomy (DEVICE).
Who is sponsoring clinical trial NCT04793581?
This trial is sponsored by Avinger, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04793581 being conducted?
This trial has 2 study locations across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Arterial Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04793581's enrollment target sits among peer trials
60 49th of 79 higher than 30 of 79 other Peripheral Arterial Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Peripheral Arterial Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
SELUTION4BTK Trial
RECRUITING · NA
-
MitoQ Treatment of Claudication: Myofiber and Micro-vessel Pathology
RECRUITING · NA
-
Ultrasound Perfusion Estimation for Assessment of Peripheral Arterial Disease
RECRUITING · NA
-
Prehabilitation and Rehabilitation in PAD
RECRUITING · NA
-
Replexa+ Shortwave Diathermy Device for Patients Diagnosed With Peripheral Artery Disease and Peripheral Neuropathy
RECRUITING · NA
-
Leg Exercise Assistive Paddling (LEAP) Therapy for Peripheral Artery Disease
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI